PT Kalbe Farma Tbk. (IDX:KLBF)
Indonesia · Delayed Price · Currency is IDR 1,000.00
+20.00 (2.04%)
Apr 15, 2026, 9:40 AM WIB
PT Kalbe Farma Tbk. Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 35,324,544 | 32,627,776 | 30,449,134 | 28,933,503 | 26,261,195 | |
Revenue Growth (YoY) | 8.27% | 7.16% | 5.24% | 10.18% | 13.62% |
Cost of Revenue | 21,531,187 | 19,904,640 | 18,897,645 | 17,414,902 | 15,156,133 |
Gross Profit | 13,793,357 | 12,723,136 | 11,551,489 | 11,518,601 | 11,105,061 |
Selling, General & Admin | 8,690,279 | 8,091,947 | 7,591,031 | 7,008,307 | 6,800,994 |
Research & Development | 499,711 | 471,600 | 322,297 | 286,805 | 285,159 |
Other Operating Expenses | 24,483 | 58,243 | -11,322 | -24,730 | -11,954 |
Operating Expenses | 9,214,473 | 8,621,790 | 7,902,006 | 7,270,382 | 7,074,199 |
Operating Income | 4,578,884 | 4,101,346 | 3,649,483 | 4,248,219 | 4,030,862 |
Interest Expense | -35,247 | -56,319 | -82,958 | -41,226 | -45,486 |
Interest & Investment Income | 179,197 | 179,101 | 88,218 | 81,827 | 110,792 |
Earnings From Equity Investments | 68,193 | 28,288 | 26,972 | 36,498 | 80,070 |
Currency Exchange Gain (Loss) | -34,845 | 22,025 | -55,928 | 155,833 | -20,022 |
Other Non Operating Income (Expenses) | -15,547 | -12,915 | -12,146 | -13,833 | -11,898 |
EBT Excluding Unusual Items | 4,740,635 | 4,261,526 | 3,613,641 | 4,467,318 | 4,144,318 |
Gain (Loss) on Sale of Investments | - | - | 15,850 | 12,105 | 20,305 |
Gain (Loss) on Sale of Assets | 71,707 | -8,751 | 1,093 | 3,038 | 7,782 |
Pretax Income | 4,812,342 | 4,252,775 | 3,630,584 | 4,482,461 | 4,172,405 |
Income Tax Expense | 1,067,967 | 1,006,205 | 852,179 | 1,032,378 | 940,397 |
Earnings From Continuing Operations | 3,744,375 | 3,246,570 | 2,778,405 | 3,450,083 | 3,232,008 |
Minority Interest in Earnings | -79,377 | -5,933 | -11,657 | -67,874 | -48,386 |
Net Income | 3,664,998 | 3,240,637 | 2,766,748 | 3,382,210 | 3,183,621 |
Net Income to Common | 3,664,998 | 3,240,637 | 2,766,748 | 3,382,210 | 3,183,621 |
Net Income Growth | 13.10% | 17.13% | -18.20% | 6.24% | 16.48% |
Shares Outstanding (Basic) | 45,524 | 46,187 | 46,256 | 46,516 | 46,873 |
Shares Outstanding (Diluted) | 45,524 | 46,187 | 46,256 | 46,516 | 46,873 |
Shares Change (YoY) | -1.43% | -0.15% | -0.56% | -0.76% | -0.00% |
EPS (Basic) | 80.51 | 70.16 | 59.81 | 72.71 | 67.92 |
EPS (Diluted) | 80.51 | 70.16 | 59.81 | 72.71 | 67.92 |
EPS Growth | 14.74% | 17.30% | -17.74% | 7.05% | 16.48% |
Free Cash Flow | 2,544,854 | 3,877,270 | 2,026,545 | 566,431 | 2,322,036 |
Free Cash Flow Per Share | 55.90 | 83.95 | 43.81 | 12.18 | 49.54 |
Dividend Per Share | - | 36.000 | 31.000 | 38.000 | 35.000 |
Dividend Growth | - | 16.13% | -18.42% | 8.57% | 25.00% |
Gross Margin | 39.05% | 39.00% | 37.94% | 39.81% | 42.29% |
Operating Margin | 12.96% | 12.57% | 11.99% | 14.68% | 15.35% |
Profit Margin | 10.38% | 9.93% | 9.09% | 11.69% | 12.12% |
Free Cash Flow Margin | 7.20% | 11.88% | 6.66% | 1.96% | 8.84% |
EBITDA | 5,346,191 | 4,817,446 | 4,314,625 | 4,907,579 | 4,649,287 |
EBITDA Margin | 15.13% | 14.77% | 14.17% | 16.96% | 17.70% |
D&A For EBITDA | 767,307 | 716,100 | 665,142 | 659,360 | 618,424 |
EBIT | 4,578,884 | 4,101,346 | 3,649,483 | 4,248,219 | 4,030,862 |
EBIT Margin | 12.96% | 12.57% | 11.99% | 14.68% | 15.35% |
Effective Tax Rate | 22.19% | 23.66% | 23.47% | 23.03% | 22.54% |
Advertising Expenses | 2,881,667 | 2,307,240 | 2,133,714 | 2,062,426 | 1,999,089 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.